REIT - Office
Compare Stocks
2 / 10Stock Comparison
NYC vs AFCG
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Specialty
NYC vs AFCG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Office | REIT - Specialty |
| Market Cap | $20M | $73M |
| Revenue (TTM) | $39M | $6M |
| Net Income (TTM) | $-21M | $-20M |
| Gross Margin | 6.2% | -76.6% |
| Operating Margin | -168.6% | -124.7% |
| Total Debt | $403M | $76M |
| Cash & Equiv. | $10M | $39M |
NYC vs AFCG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| American Strategic … (NYC) | 100 | 11.7 | -88.3% |
| Advanced Flower Cap… (AFCG) | 100 | 21.5 | -78.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYC vs AFCG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NYC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta -0.26
- Rev growth -1.8%, EPS growth -18.8%, 3Y rev CAGR -4.3%
- Lower volatility, beta -0.26, current ratio 2.29x
AFCG is the clearest fit if your priority is long-term compounding.
- -42.4% 10Y total return vs NYC's -93.8%
- Lower D/E ratio (43.5% vs 471.0%)
- 28.1% yield; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.8% FFO/revenue growth vs AFCG's -39.6% | |
| Quality / Margins | -53.6% margin vs AFCG's -333.9% | |
| Stability / Safety | Lower D/E ratio (43.5% vs 471.0%) | |
| Dividends | 28.1% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -30.7% vs AFCG's -35.5% | |
| Efficiency (ROA) | -4.7% ROA vs AFCG's -6.4%, ROIC -15.8% vs -4.1% |
NYC vs AFCG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NYC vs AFCG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NYC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NYC is the larger business by revenue, generating $39M annually — 6.6x AFCG's $6M. Profitability is closely matched — net margins range from -53.6% (NYC) to -3.3% (AFCG). On growth, AFCG holds the edge at +64.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $39M | $6M |
| EBITDAEarnings before interest/tax | -$53M | -$16M |
| Net IncomeAfter-tax profit | -$21M | -$20M |
| Free Cash FlowCash after capex | -$13M | -$24M |
| Gross MarginGross profit ÷ Revenue | +6.2% | -76.6% |
| Operating MarginEBIT ÷ Revenue | -168.6% | -124.7% |
| Net MarginNet income ÷ Revenue | -53.6% | -3.3% |
| FCF MarginFCF ÷ Revenue | -33.4% | -3.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +64.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | +16.7% |
Valuation Metrics
NYC leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $20M | $73M |
| Enterprise ValueMkt cap + debt − cash | $413M | $110M |
| Trailing P/EPrice ÷ TTM EPS | -0.14x | -3.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.33x | 2.32x |
| Price / BookPrice ÷ Book value/share | 0.23x | 0.39x |
| Price / FCFMarket cap ÷ FCF | — | 6.47x |
Profitability & Efficiency
AFCG leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
AFCG delivers a -11.1% return on equity — every $100 of shareholder capital generates $-11 in annual profit, vs $-30 for NYC. AFCG carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYC's 4.71x. On the Piotroski fundamental quality scale (0–9), AFCG scores 4/9 vs NYC's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -29.6% | -11.1% |
| ROA (TTM)Return on assets | -4.7% | -6.4% |
| ROICReturn on invested capital | -15.8% | -4.1% |
| ROCEReturn on capital employed | -20.8% | -5.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 4.71x | 0.43x |
| Net DebtTotal debt minus cash | $393M | $38M |
| Cash & Equiv.Liquid assets | $10M | $39M |
| Total DebtShort + long-term debt | $403M | $76M |
| Interest CoverageEBIT ÷ Interest expense | -6.22x | -2.15x |
Total Returns (Dividends Reinvested)
Evenly matched — NYC and AFCG each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AFCG five years ago would be worth $5,539 today (with dividends reinvested), compared to $1,191 for NYC. Over the past 12 months, NYC leads with a -30.7% total return vs AFCG's -35.5%. The 3-year compound annual growth rate (CAGR) favors NYC at -2.1% vs AFCG's -7.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -6.0% | +10.2% |
| 1-Year ReturnPast 12 months | -30.7% | -35.5% |
| 3-Year ReturnCumulative with dividends | -6.0% | -20.1% |
| 5-Year ReturnCumulative with dividends | -88.1% | -44.6% |
| 10-Year ReturnCumulative with dividends | -93.8% | -42.4% |
| CAGR (3Y)Annualised 3-year return | -2.1% | -7.2% |
Risk & Volatility
Evenly matched — NYC and AFCG each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYC is the less volatile stock with a -0.26 beta — it tends to amplify market swings less than AFCG's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AFCG currently trades 52.6% from its 52-week high vs NYC's 49.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.26x | 1.86x |
| 52-Week HighHighest price in past year | $16.30 | $5.87 |
| 52-Week LowLowest price in past year | $7.03 | $2.06 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +52.6% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 48.2 |
| Avg Volume (50D)Average daily shares traded | 2K | 235K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
AFCG is the only dividend payer here at 28.10% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +28.1% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | 0.0% |
NYC leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). AFCG leads in 1 (Profitability & Efficiency). 2 tied.
NYC vs AFCG: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NYC or AFCG a better buy right now?
For growth investors, American Strategic Investment Co.
(NYC) is the stronger pick with -1. 8% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NYC or AFCG?
Over the past 5 years, Advanced Flower Capital Inc.
(AFCG) delivered a total return of -44. 6%, compared to -88. 1% for American Strategic Investment Co. (NYC). Over 10 years, the gap is even starker: AFCG returned -42. 4% versus NYC's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NYC or AFCG?
By beta (market sensitivity over 5 years), American Strategic Investment Co.
(NYC) is the lower-risk stock at -0. 26β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately -803% more volatile than NYC relative to the S&P 500. On balance sheet safety, Advanced Flower Capital Inc. (AFCG) carries a lower debt/equity ratio of 43% versus 5% for American Strategic Investment Co. — giving it more financial flexibility in a downturn.
04Which is growing faster — NYC or AFCG?
By revenue growth (latest reported year), American Strategic Investment Co.
(NYC) is pulling ahead at -1. 8% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: American Strategic Investment Co. grew EPS -18. 8% year-over-year, compared to -218. 8% for Advanced Flower Capital Inc.. Over a 3-year CAGR, NYC leads at -4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NYC or AFCG?
Advanced Flower Capital Inc.
(AFCG) is the more profitable company, earning -66. 0% net margin versus -228. 3% for American Strategic Investment Co. — meaning it keeps -66. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AFCG leads at -43. 6% versus -196. 9% for NYC. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NYC or AFCG?
In this comparison, AFCG (28.
1% yield) pays a dividend. NYC does not pay a meaningful dividend and should not be held primarily for income.
07Is NYC or AFCG better for a retirement portfolio?
For long-horizon retirement investors, American Strategic Investment Co.
(NYC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 26)). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NYC: -93. 8%, AFCG: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NYC and AFCG?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYC is a small-cap quality compounder stock; AFCG is a small-cap income-oriented stock. AFCG pays a dividend while NYC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.